GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jenscare Scientific Co Ltd (HKSE:09877) » Definitions » Equity-to-Asset

Jenscare Scientific Co (HKSE:09877) Equity-to-Asset : 0.93 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Jenscare Scientific Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Jenscare Scientific Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,348.49 Mil. Jenscare Scientific Co's Total Assets for the quarter that ended in Dec. 2023 was HK$1,451.55 Mil.

The historical rank and industry rank for Jenscare Scientific Co's Equity-to-Asset or its related term are showing as below:

HKSE:09877' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.93   Med: 0.95   Max: 0.96
Current: 0.93

During the past 4 years, the highest Equity to Asset Ratio of Jenscare Scientific Co was 0.96. The lowest was 0.93. And the median was 0.95.

HKSE:09877's Equity-to-Asset is ranked better than
95.51% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs HKSE:09877: 0.93

Jenscare Scientific Co Equity-to-Asset Historical Data

The historical data trend for Jenscare Scientific Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenscare Scientific Co Equity-to-Asset Chart

Jenscare Scientific Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
0.95 0.96 0.96 0.93

Jenscare Scientific Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial 0.96 0.97 0.96 0.96 0.93

Competitive Comparison of Jenscare Scientific Co's Equity-to-Asset

For the Medical Devices subindustry, Jenscare Scientific Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jenscare Scientific Co's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Jenscare Scientific Co's Equity-to-Asset falls into.



Jenscare Scientific Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Jenscare Scientific Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1348.49/1451.545
=

Jenscare Scientific Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1348.49/1451.545
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jenscare Scientific Co  (HKSE:09877) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Jenscare Scientific Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Jenscare Scientific Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Jenscare Scientific Co (HKSE:09877) Business Description

Traded in Other Exchanges
N/A
Address
No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN
Jenscare Scientific Co Ltd is a China-based company mainly engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.
Executives
Shanghai Jiachen Investment Co.,ltd 2201 Interest of corporation controlled by you
Li Hui 2501 Other
Lv Shiwen 2501 Other
Ningbo Dixiang Venture Capital Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Shidi Industrial Development Co., Ltd. 2501 Other
Ningbo Sangdi Investment Management L.p. (limited Partnership) 2101 Beneficial owner
Ningbo Linfeng Biotechnology Co., Ltd. 2101 Beneficial owner
Pan Fei 2201 Interest of corporation controlled by you
Hainan Yize Medical Technology Co., Limited 2201 Interest of corporation controlled by you
Hainan Maidi Enterprise Management L.p. (limited Partnership) 2101 Beneficial owner
Hainan Hualing Investment L.p. (limited Partnership) 2101 Beneficial owner
Hangzhou Chende Investment Partnership (limited Partnership) 2101 Beneficial owner
Ningbo Mukang Venture Capital Partnership (limited Partnership)
Li Hui

Jenscare Scientific Co (HKSE:09877) Headlines

No Headlines